Novartis acquires cancer immunotherapy play CoStim

Novartis AG (NYSE:NVS; SIX:NOVN) acquired CoStim Pharmaceuticals Inc. (Cambridge, Mass.) for an undisclosed amount to gain CoStim's portfolio of late-stage discovery programs focused on immune checkpo...